A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Prostate Cancer
Interventions: DIETARY_SUPPLEMENT: Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus Dietary Supplement (RaproCell)|DRUG: Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel) plus placebo|DRUG: Chemotherapeutic agent A(Docetaxel),B(Cisplatin) or C(Docetaxel).
Sponsor: Optimal Health Research